ATAD3A and head and neck squamous cell carcinoma: Coupled with rigorous in vitro and in vivo validations, this study gains unprecedented insights into the mitochondrial oncogenic signaling mediated by ATAD3A as well as unraveling it as a promising molecular target for anti-HNSCC [9].